SEC Form 4 · accession 0001140361-17-015704
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Beever
Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 12, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.618 | Apr 11, 2017 | A | 110,000 | A | Apr 11, 2018 | Apr 11, 2027 | Common Stock | 110,000 | 110,000 | D |